REQUEST A DEMO
Total
USD $0.00
Search more companies

Ko-Do Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: KO-DO PHARMA Egeszsegugyi, Kereskedelmi es Szolgaltato Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Ko-Do Pharma Kft. is based in Hungary. The head office is in Budapest. It operates in the Pharmacies and Drug Stores industry. Ko-Do Pharma Kft. was incorporated on January 29, 2007. Ko-Do Pharma Kft. currently employs 3 (2024) people. In its most recent financial highlights, the company reported a net sales revenue drop of 0.54% in 2023. A negative growth of 26.72% was recorded in its total assets. In 2023, Ko-Do Pharma Kft.’s net profit margin increased by 2.88%.

Headquarters
Kozraktar utca 2. a. ep.
Budapest; Budapest; Postal Code: 1093

Contact Details: Purchase the Ko-Do Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Ko-Do Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Ko-Do Pharma Kft. report to view the information.
Registered Capital:
Purchase the Ko-Do Pharma Kft. report to view the information.
Incorporation Date:
January 29, 2007
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Ko-Do Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-0.54%
Total operating revenue
-0.23%
Operating profit (EBIT)
123.43%
EBITDA
71.38%
Net Profit (Loss) for the Period
902.2%
Total assets
-26.72%
Total equity
154.76%
Operating Profit Margin (ROS)
2.75%
Net Profit Margin
2.88%
Return on Equity (ROE)
45.31%
Quick Ratio
-0.1%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?